Showing results (81-90 of 159) with videos related to

Sort By:
Pageof 16
Journal of Thrombosis and Haemostasis : JTH|August 1, 2007
Restoring hemostatic thrombin generation at the time of cutaneous wounding does not normalize healing in hemophilia BA McDonald, M Hoffman, U Hedner, et al.
Thrombosis and Haemostasis|August 31, 1977
Treatment of anti-factor VIII antibodiesP M Blatt, G C White, C W McMillan, et al.
Thrombosis Research|August 1, 1982
Measurement of human factor IXa activity in an isolated factor X activation systemM J Griffith, H M Reisner, R L Lundblad, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 1, 1983
Identification of the molecular defect in factor IX Chapel Hill: substitution of histidine for arginine at position 145C M Noyes, M J Griffith, H R Roberts, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|July 2, 1999
Tissue factor de-encryption: ionophore treatment induces changes in tissue factor activity by phosphatidylserine-dependent and -independent mechanismsA S Wolberg, D M Monroe, H R Roberts, et al.
Transfusion Science|May 7, 1998
Mammalian recombinant coagulation proteins: structure and functionG C White, E M Pickens, D K Liles, et al.
Transfusion|September 1, 1979
Antithrombin III in fresh frozen plasma, cryoprecipitate, and cryoprecipitate-depleted plasmaP D Mintz, P M Blatt, W J Kuhns, et al.
The Journal of Laboratory and Clinical Medicine|March 1, 1986
Granulocyte lysosomal cationic protein alters fibrin assembly: a possible mechanism for granulocyte control of clot structureM E Carr, D A Gabriel, J C Herion, et al.
Biochemistry|February 18, 1992
The endothelial cell binding determinant of human factor IX resides in the gamma-carboxyglutamic acid domainJ R Toomey, K J Smith, H R Roberts, et al.
Pageof 16